Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 27, 2022

SELL
$19.63 - $26.62 $155,312 - $210,617
-7,912 Closed
0 $0
Q1 2021

Apr 26, 2021

SELL
$27.85 - $34.49 $39,352 - $48,734
-1,413 Reduced 15.15%
7,912 $233,000
Q2 2020

Aug 12, 2020

SELL
$18.94 - $24.93 $17.3 Million - $22.8 Million
-915,213 Reduced 98.99%
9,325 $200,000
Q1 2020

May 13, 2020

BUY
$16.68 - $32.25 $2.49 Million - $4.81 Million
149,196 Added 19.24%
924,538 $20.7 Million
Q4 2019

Feb 14, 2020

SELL
$25.29 - $29.45 $5.7 Million - $6.63 Million
-225,260 Reduced 22.51%
775,342 $22.8 Million
Q3 2019

Nov 13, 2019

BUY
$25.62 - $34.96 $17.1 Million - $23.4 Million
668,947 Added 201.7%
1,000,602 $26.6 Million
Q2 2019

Aug 12, 2019

SELL
$31.11 - $34.79 $88,632 - $99,116
-2,849 Reduced 0.85%
331,655 $11.2 Million
Q1 2019

May 15, 2019

BUY
$29.0 - $32.83 $9.7 Million - $11 Million
334,504 New
334,504 $10.7 Million

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.35B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Tran Capital Management, L.P. Portfolio

Follow Tran Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tran Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tran Capital Management, L.P. with notifications on news.